The role of allergies (A) and tobacco exposure (T) in Obstructive Sleep Apnea Syndrome (OSAS) Type I/II (I/II) in children, and Sublingual Immunotherapy (SLIT) for the treatment of children with OSAS I/II with an Allergic Profile (AP)

Kalomoira Kefala (Ile-de-France, France), Philippe Guerin

Source: Sleep and Breathing Conference 2021
Number: 0
Disease area: Sleep and breathing disorders

E-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Kalomoira Kefala (Ile-de-France, France), Philippe Guerin. The role of allergies (A) and tobacco exposure (T) in Obstructive Sleep Apnea Syndrome (OSAS) Type I/II (I/II) in children, and Sublingual Immunotherapy (SLIT) for the treatment of children with OSAS I/II with an Allergic Profile (AP). Sleep and Breathing Conference 2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: